business News

Stay updated with the latest business news, articles, and updates.

Trump says he'll block defense contractor stock buybacks. Here's what his executive order actually does. - Business Insider
business

Trump says he'll block defense contractor stock buybacks. Here's what his executive order actually does. - Business Insider

Defense Secretary Pete Hegseth now has leverage over defense contractors' financial decisions, from executive comp to shareholder payouts.

Business InsiderJacob Shamsian
business

Statement regarding Glencore plc (“Glencore”) - Rio Tinto

Riotinto.com
GM takes $6 billion hit as cost of backing away from EVs - CNN
business

GM takes $6 billion hit as cost of backing away from EVs - CNN

General Motors on Thursday said it will take an additional $6 billion hit against its earnings as result of it pulling back on its electric vehicle plans.

CNNChris Isidore
Inside Daniel Lurie’s handling of Waymo crisis during S.F. power outages - San Francisco Chronicle
business

Inside Daniel Lurie’s handling of Waymo crisis during S.F. power outages - San Francisco Chronicle

Mayor Daniel Lurie’s texts with Waymo CEO Tekedra Mawakana show how he sought to end the robotaxi traffic chaos during San Francisco's PG&E power outages.

San Francisco ChronicleRachel Swan, J.D. Morris
Merck in talks to buy biotech Revolution Medicines, FT reports - Yahoo Finance
business

Merck in talks to buy biotech Revolution Medicines, FT reports - Yahoo Finance

Jan 8 () - Merck is in talks to ​buy cancer drug developer ‌Revolution Medicines, the Financial Times ‌reported on Thursday, citing people familiar with the...

Yahoo EntertainmentReuters
Merck in talks to buy cancer drugmaker Revolution Medicines for up to $32bn - Financial Times
business

Merck in talks to buy cancer drugmaker Revolution Medicines for up to $32bn - Financial Times

US company is attempting to acquire the maker of a new treatment for pancreatic cancer

Financial TimesPatrick Temple-West, Oliver Barnes
Merck in talks to buy cancer drugmaker Revolution Medicines - Financial Times
business

Merck in talks to buy cancer drugmaker Revolution Medicines - Financial Times

US company is attempting to acquire the maker of a new treatment for pancreatic cancer

Financial TimesPatrick Temple-West, Oliver Barnes
Dividend growth stocks offer attractive returns with less risk, Nuveen finds. Analysts like these names - CNBC
business

Dividend growth stocks offer attractive returns with less risk, Nuveen finds. Analysts like these names - CNBC

Companies that regularly raise their dividends can help protect portfolios in volatile times. A CNBC Pro screen turned up several names beloved by Wall Street.

CNBCDarla Mercado, CFP®
Why Are Grok and X Still Available in App Stores? - WIRED
business

Why Are Grok and X Still Available in App Stores? - WIRED

Elon Musk’s chatbot has been used to generate thousands of sexualized images of adults and apparent minors. Apple and Google have removed other “nudify” apps—but continue to host X and Grok.

WiredCaroline Haskins
Datavault AI's New York and Philadelphia Edge Network will be Completed in Second Quarter and Unlock Multi-Billion Dollar Markets through AI Driven Data Monetization - Datavault AI
business

Datavault AI's New York and Philadelphia Edge Network will be Completed in Second Quarter and Unlock Multi-Billion Dollar Markets through AI Driven Data Monetization - Datavault AI

New York and Philadelphia Edge Network Activation Positions Datavault AI to Capture Significant Share of Insurance and Financial Sectors,…...

Datavaultsite.com
CrowdStrike stock breaks its win streak. But the reason is not what you may think - CNBC
business

CrowdStrike stock breaks its win streak. But the reason is not what you may think - CNBC

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.

CNBCJeff Marks, Morgan Chittum
business

Trump housing plan likely won't help the affordability crisis that much - Axios

AxiosAxios
Google cofounders Sergey Brin and Larry Page moved an LLC out of California ahead of proposed billionaire's tax - Business Insider
business

Google cofounders Sergey Brin and Larry Page moved an LLC out of California ahead of proposed billionaire's tax - Business Insider

The LLC moved as California's ultrarich weigh leaving ahead of a proposed tax on billionaires that would take effect retroactively starting January 1.

Business InsiderJulia Hornstein, Jack Newsham
Glencore and Rio Tinto resume talks on $260bn mining megadeal - Financial Times
business

Glencore and Rio Tinto resume talks on $260bn mining megadeal - Financial Times

Discussions over a tie-up to create the world’s largest mining group come as race to secure copper reshapes the sector

Financial TimesJulie Steinberg, Leslie Hook, Mercedes Ruehl, Arash Massoudi
Glencore and Rio Tinto resume talks on mining megadeal - Financial Times
business

Glencore and Rio Tinto resume talks on mining megadeal - Financial Times

Discussions over a tie-up to create world’s largest mining group come as race to secure copper reshapes sector

Financial TimesJulie Steinberg, Leslie Hook, Mercedes Ruehl, Arash Massoudi
Apple (AAPL) Engineering Chief John Ternus Is Frontrunner to Succeed Tim Cook as CEO - TipRanks
business

Apple (AAPL) Engineering Chief John Ternus Is Frontrunner to Succeed Tim Cook as CEO - TipRanks

The current chief executive is said to be exhausted.

Tipranks.comJoel Baglole
Trump threatens to ban institutional investors from buying single-family homes - 6abc Philadelphia
business

Trump threatens to ban institutional investors from buying single-family homes - 6abc Philadelphia

President Trump said that he intends to ban large institutional investors from buying additional single-family homes.

WPVI-TVNathaniel Meyersohn, CNN
Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with active psoriatic arthritis and obesity or overweight - Eli Lilly
business

Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with active psoriatic arthritis and obesity or overweight - Eli Lilly

The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts.

Lilly.com
Grok assumes users seeking images of underage girls have “good intent” - Ars Technica
business

Grok assumes users seeking images of underage girls have “good intent” - Ars Technica

Expert explains how simple it could be to tweak Grok to block CSAM outputs.

Ars TechnicaAshley Belanger
business

Stock Market Today: Defense Stocks Rally; Dow Gains — Live Updates - The Wall Street Journal

The Wall Street JournalThe Wall Street Journal